⌘K

Login Start Free

Home/Filings/4/0001439222-21-000031

4//SEC Filing

Miles Darrin 4

Accession 0001439222-21-000031

CIK 0001439222other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 4:14 PM ET

Size

6.1 KB

Accession

0001439222-21-000031

Insider Transaction Report

Form 4

Period: 2021-03-01

AGIOS PHARMACEUTICALS, INC.AGIO

Chief Commercial Officer

Transactions

Sale
Common stock
2021-03-05$48.58/sh−500$24,290→ 10,671 total
Sale
Common stock
2021-03-01$47.99/sh−2,200$105,578→ 11,171 total

Footnotes (1)

[F1]Includes 314 shares purchased through the Company's employee stock purchase plan.

Documents

1 file

4
wf-form4_161592564145666.xmlPrimary
FORM 4

Issuer

AGIOS PHARMACEUTICALS, INC.

CIK 0001439222

Entity typeother

Related Parties

1

filerCIK 0001840076

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 4:14 PM ET
Size: 6.1 KB

View on SEC.gov